TotalMarketCap

Cardio Diagnostics

CDIONasdaq United StatesHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$5.164 M

$1.75 +5.76%

Close of 6 Nov 2026

As of 6 Nov 2026, Cardio Diagnostics (CDIO) has a market capitalization of $5.16M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$14.8K

#3601 by revenue

Earnings

-$6.50M

Loss-making

Shares outstanding

2,959,469

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Cardio Diagnostics lists more than one class of stock. Company figures above cover all classes combined.

CDIOW

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →
  1. #14BiomericaBMRA$7.40M
  2. #15VolitionrxVNRX$5.84M
  3. #16Cardio DiagnosticsCDIO$5.16M
  4. #17Trinity BiotechTRIB$4.79M
  5. #18Q/C TechnologiesQCLS$2.71M

What if Cardio Diagnostics were worth as much as…

Open the what-if tool →

Gold $28.2T

$9,541,197

Per share 5,467,735× higher

Bitcoin $1.53T

$516,257.54

Per share 295,850× higher

Apple $5.02T

$1,694,825

Per share 971,247× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Cardio Diagnostics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.